Sandoz Inc.: Sandoz Inc. enters exclusive agreement to distribute and commercialize SYMJEPI™ (epinephrine) in the US
Sandoz Inc. (Sandoz), a Novartis Division, today announced an exclusive agreement with Adamis Pharmaceuticals Corporation (Adamis) whereby Sandoz will distribute and commercialize SYMJEPI™ (epinephrine) 0.3 mg Injection in the United States. Read More »